This company has shut down. Epiterna is no longer operating — its last tracked round was a Corporate Round in 2023.
Explore the Startup GraveyardEpiterna is a biotechnology company that focuses on long-term medicines for humans and animals.
Epiterna has raised $11.0M in total funding. The most recent round was Corporate Round. The last funding was announced in August 2023.
Epiterna's investors include Prima Materia.
Epiterna is headquartered in Epalinges, Switzerland.
Epiterna is a biotechnology company that focuses on long-term medicines for humans and animals.
Epiterna is at the Corporate Round stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Epiterna — Funding & Investors." VCBacked, August 1, 2023, https://www.vcbacked.co/company/epiterna. Accessed August 15, 2026.
VCBacked. (2023). Epiterna — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/epiterna
{{cite web |title=Epiterna — Funding & Investors |url=https://www.vcbacked.co/company/epiterna |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated